Clinical Trial Update: Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Telitacicept in pediatric patients with IgA nephropathy or IgA vasculitis nephritis, status not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy
• Iga Vasculitis Nephritis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Guixia Ding | Conditions: IgA Nephropathy (IgAN), IgAVN | Phase 3 | Status: NOT_YET_RECRUITING